[181]
Early Prostate Cancer: Questions and Answers
[39,2 KB]
From [www.nci.nih.gov] Last viewed: 07.09.2006
5.23
11/10/03
Page 1
Early Prostate Cancer : Questions and Answers
1.
What is the prostate ?
The prostate is a gland in the male reproductive system. The prostate makes and
stores a component of semen and is located near the bladder and the rectum. The
prostate surrounds part of the urethra, the tube that empties urine from the
bladder. A healthy prostate is about the size of a walnut. If the prostate grows
too large, the flow of urine can be slowed or stopped.
Key Points
• The prostate is a gland in the male reproductive system (see Question 1).
• The most common risk factor for prostate cancer is age (see Question 3).
• Prostate cancer often does not cause symptoms for many years. By the
time symptoms occur, the disease may have spread beyond the prostate
(see Question 4).
• The symptoms of prostate cancer can also be caused by noncancerous ...
[182]
Prostate cancer where to start sheet
[32,8 KB]
From [www.ottawahospital.on.ca] Last viewed: 07.09.2006
Where to Start Sources of Information on Prostate Cancer
Suggestions for resources when you begin to look for
information about prostate cancer .
Prepared by the Ninon Bourque Patient Resource Library
The Ottawa Hospital Regional Cancer Centre
501 Smyth Road, Ottawa, ON, K1H 8L6
613-737-7700 ext 70107
These resources are provided for information purposes only and are not intended as a substitute for
medical care. Inclusion of a resource does not imply endorsement by The Ottawa Hospital. If you
have any questions about your healthcare, please consult your healthcare provider.
If you would like to have more information about this topic, please contact the Ninon Bourque Patient
Resource Library at 613-737-7700 ext. 70107 or consumerhealth@ottawahospital.on.ca .
Basic
Information
Prostate cancer : what you need to know .
A 12-page booklet providing ...
[183]
Prostate Cancer Early Detection
[3087,8 KB]
From [utm-ext01a.mdacc.tmc.edu] Last viewed: 07.09.2006
Prostate Cancer Early Detection
(Page 1 of 6)
The objective of this guideline is to maximize the detection of prostate cancer not to address whether or not early
detection is appropriate. It is neither the intent nor suggestion that all men diagnosed with prostate cancer require
treatment. It is inherent that as we maximize the detection of prostate cancer , we will increase the detection of
currently defined significant and insignificant prostate cancers. Due to the unique biology of prostate cancer ,
over-treatment is of concern because the results can potentially impact the quality of life. The value of prostate
cancer screening is controversial. For those men who, after informed consent, elect to undergo early detection,
these general guidelines, in combination with patient preference, are the majority recommendations based on expert
opinion of the GU Center Faculty at the University of Texas, MDACC. ...
[184]
Prostate Cancer Leaf 05.indd
[177,0 KB]
From [www.tenovus.com] Last viewed: 07.09.2006
Know your body and keep it safe
Prostate
Problems
Guide to
Page 2
2
3
8
out of
10
men don’t know
where their prostate gland is.
The prostate gland is found at the
bottom of your bladder wrapped
around the tube (called the
urethra) which carries urine out of
the penis. It’s about the size of a
walnut and its job is to make the
liquid that carries your sperm.
8
out of
10
men will need
treatment for prostate problems.
The prostate starts to develop at
puberty and at around the age of
40 the prostate grows again, which
for many men is when problems
may begin. The unwanted growth is
called “Benign Prostatic Hyperplasia”
or BPH for short. It is not cancer
and it’s rare before the age of 50.
But, next ...
[185]
Chromosome aberrations in peripheral blood lymphocytes from ...
[16,1 KB]
From [www.gsi.de] Last viewed: 07.09.2006
Chromosome aberrations in peripheral blood lymphocytes from patients
with primary prostate cancer before radiotherapy
Hana Hofman-Hüther
1
, Oliver Balzer
2
and Patricia Virsik-Köpp
2
1
Dept. Radiotherapy and Radiooncology;
2
Dept. Hygiene and Environmental Medicine
Medical Faculty, University of Goettingen, Germany
Spontaneous level of chromosome aberrations is considered
to be indicative of inherent cancer predisposition, which
plays an important role in cancer incidence. We have studied
spontaneous chromosome aberrations in peripheral blood
lymphocytes of patients with prostate cancer before their
treatment with conventional therapy.
Twelve patients with Stage T1-T2 primary prostate cancer
were included in this study. Four healthy male donors served
as controls for comparison, and the yields of chromosome ...
[186]
Prostate Cancer and Exposure to Ionizing Radiation Summary ...
[29,0 KB]
From [www.jsi.com] Last viewed: 07.09.2006
Center for Environmental Health Studies
(617) 482-9485
44 Farnsworth Street, Boston, MA 02210
http://www.jsi.com
Prostate Cancer and Exposure to Ionizing Radiation
1
Prostate Cancer and
Exposure to Ionizing Radiation
Summary:
Evidence has been recorded of an connection between cancers of the prostate and
exposure to ionizing radiation. This connection is supported by evidence from studies of nuclear workers in
England who have been exposed to ionizing radiation. The National Research Council’s, on the other hand,
has determined that the prostate is relatively insensitive to ionizing radiation. Prostate cancer is not
designated as a “specified” cancer under the Energy Employees Occupational Illness Compensation
Program Act. Historically, prostate cancer incidence has been high for Los Alamos County while prostate
cancer mortality has been low compared ...
[187]
WHAT EVERY MAN SHOULD KNOW ABOUT PROSTATE CANCER _3_
[17,9 KB]
From [www.lefprostate.org] Last viewed: 07.09.2006
WHAT EVERY MAN SHOULD KNOW ABOUT PROSTATE CANCER
Prostate cancer often has no symptoms. This is why screening is so important for all men starting
as young as age 40, particularly if they are at high risk due to family history or racial background.
Black men have the highest incidence of prostate cancer , followed by Hispanics. Many current
guidelines specify that screening for all men should begin at age 50.
Any persistent increase in PSA over time at any level, even within the normal range, should be
investigated to rule out prostate cancer . If patients and doctors were to keep a PSA record or a
graph, noting any changes and noting the trend over time in PSA values, countless lives would be
saved. The quality of life for many men diagnosed with prostate cancer is better preserved with
early detection of the disease versus diagnosis with advanced disease. Prostate cancer detected
early provides many options ...
[188]
Prostate cancer (CaP) is the most frequently diagnosed solid tumor ...
[12,4 KB]
From [www.fhcrc.org] Last viewed: 07.09.2006
PROJECT 1 – MOLECULAR PREDICTORS OF PROSTATE CANCER PROGRESSION & MORTALITY
Prostate cancer (CaP) is the most frequently diagnosed solid tumor and the second leading cause of cancer deaths among
U.S. men. Despite the substantial morbidity and mortality associated with CaP, limited attention has been focused on
elucidation of factors that predict clinical disease progression or mortality. Environmental and genetic factors may play
a role in the development of aggressive, life-threatening CaP. We hypothesize that variant alleles in genes involved in
the androgen/growth factor/antioxidant pathways confer a higher risk for disease progression and mortality.
Specifically, we propose to genotype a population-based cohort of CaP patients to address the following hypotheses:
1) Heterozygotes and homozygotes for the valine allele (V89L) in the SRD5A2 gene have an increased risk of prostate
cancer progression and mortality; ...
[189]
Prostate cancer is a complex disease that presumably stratifies ...
[12,3 KB]
From [www.fhcrc.org] Last viewed: 07.09.2006
PROJECT 4 –TRANSCRIPTOME & PROTEOME STRATIFICATION OF PROSTATE CANCER ADENOCARCINOMA
PHENOTYPES
Prostate cancer is a complex disease that presumably stratifies into different types of cancers with distinct
progression rates, metastatic potentials and prognostic outcomes. We hypothesize that histologically similar primary
prostate carcinomas can be stratified into distinct categories of clinical behavior based upon profiles of their
expressed genes . We will determine the gene expression profiles of prostate carcinoma that correlate with clinical
phenotype of progression or non-progression as determined by PSA-free survival at 5 years post-therapy. The
expression profiles from the normal and neoplastic tissues of 100 individuals that have undergone radical
prostatectomy will be determined. Outcomes will be measured by following serial PSA measurements for recurrent
disease. Correlations of individual ...
[190]
Lawmakers, Celebs Target Prostate Cancer
[53,5 KB]
From [www.prostatecancerfoundation.org] Last viewed: 07.09.2006
Family Issues in
Policy and Culture
A Web site of Focus on the Family
About Us | Contact | Press
Citizen Link
Extras
Features
Citizen Magazine
Issue Archive
Subscribe/Join
Family Policy Councils
State Councils
Family News In Focus
Listen
Find a Station
Focus on Social Issues
Abstinence Policy
Bioethics/Sanctity of Life
Constitution & Govt.
Education
Gambling
Homosexuality & Gender
Marriage & Family
Origins
Persecution
Political Islam
Pornography
Worldview & Culture
Support the Ministry
Donate Online
Give Monthly
Volunteers
Creative Giving
Pray for Focus
June 17, 2005
Lawmakers, Celebs Target Prostate
Cancer
by Bill Wilson, Washington, ...
[191]
Prostate Cancer
[47,4 KB]
From [www.preventcancer.org] Last viewed: 07.09.2006
Prostate Cancer
An estimated 232,090 American men will be diagnosed with prostate cancer in 2005.
About 70 percent of all diagnosed prostate cancers are found in men older than 65.
PREVENTION
• Lead a healthy lifestyle and talk to your health care professional about screening.
• Exercise regularly.
• Eat a diet low in fat and high in fruits, vegetables and whole grains.
RISK
• Men, particularly African-American men, and men over age 50
• Men with a family history of prostate cancer
SYMPTOMS
In the early stages, there are usually no symptoms. Some men experience the following
symptoms:
• Frequent urination, especially at night
• Trouble starting or stopping urine flow
• Weak or interrupted urine flow
• Inability to urinate
• Pain or burning sensation while urinating
• Blood in the urine
• Constant pain in lower back, pelvis or upper thighs ...
[192]
Prostate Cancer
[309,9 KB]
From [www.kidneyurology.org] Last viewed: 07.09.2006
Research and Programs That Touch People
1.800.63.DONATE
www.kidneyurology.org
What You Should
Know About
Prostate Cancer
1250 Broadway, Suite 2001
New York, NY 10001
212.629.9770 or 1.800.63.DONATE
fax 212.629.5652
Visit our web site at
www.kidneyurology.org
The Kidney & Urology Foundation of America, Inc.
is a national, not-for-profit organization dedicated to
helping people avoid the debilitating effects of
kidney and urologic diseases - disorders affecting as
many as 70 million Americans today.
By funding research, medical conferences, and
interdisciplinary hospital initiatives, the Kidney &
Urology Foundation provides the leadership
necessary to promote a better understanding of
kidney and urologic diseases.
We are committed to making research and
resources accessible to patients and their families, as
well as ...
[193]
Improving the Experience of Prostate Cancer Surgery Improving the ...
[285,1 KB]
From [www.davinciprostatectomy.com] Last viewed: 07.09.2006
Improving the
Experience of
Prostate Cancer
Surgery
Robotic Prostatectomy at Wake Forest
University Baptist Medical Center
Improving the
Experience of
Prostate Cancer
Surgery
Robotic Prostatectomy at Wake Forest
University Baptist Medical Center
Piedmont Triad Edition
Page 2
Improving the Experience
of Prostate Cancer Surgery
Robotic Prostatectomy at Wake Forest
University Baptist Medical Center
cover
story
AccordingtotheAmericanCancerSociety,prostatecancercontinuesto
be the most common form of cancer found in men in the United States. In
fact,prostatecanceraloneaccountsforone-thirdofallcancersdiagnosedin
men,withapproximately180,000newcaseseachyear.Thesecondleading
cause of cancer death after lung cancer — one of six men in the U.S. will
be diagnosed with this disease during their ...
[194]
Prostate cancer: what are the treatment options? (English)
[72,3 KB]
From [www.aancart.org] Last viewed: 07.09.2006
English
April 2002
[BHC-6055]
1 / 2
D E P A R T M E N T
Prostate cancer : what are the treatment options?
Every man has a prostate , a small gland that produces some of the fluid in semen.
It is found at the base of the bladder and surrounds the urethra (the tube which
takes urine from the bladder to the penis). At some time in their lives, one in ten
men in Australia will be diagnosed with prostate cancer . This usually affects men
after the age of 50, and becomes increasingly common over the following dec-
ades. However, this cancer tends to grow slowly - most men who have it don’t die
from the disease.
What is prostate cancer ?
It’s normal for the prostate to get bigger after middle age. This can cause symp-
toms, such as needing to pass water more often. But an enlarged prostate isn’t the
same as cancer . Cancer is a malignant growth in the ...
[195]
Prostate cancer: what are the treatment options? (Chinese)
[205,6 KB]
From [www.aancart.org] Last viewed: 07.09.2006
Chinese
April 2002
[BHC-6055]
1 / 2
D E P A R T M E N T
½ :
8
?
Prostate cancer : what are the treatment options?
½,
8 ¼ + q
, ?
, 8(
7 )q!
?
2
? ½q8 50 ? , ?
8q%
(/
–
½
(q
½ ?
?, ½
q
,
àq
½? q/ ½ /q,
½?q ½?, ?
? q ½ 8 q
½ ?
,Æ Aq2/8ü
? q
Æ:
Ã
: ¼ ½ q
ä
:
X- ä+q
(Brachytherapy)
:
ä—8 8
?
+q /q
—
ä
½
q
/A?8 q(
: ? 70
?,
(?,q) äß:
/ 8Ç 2 ýq
+
%
½,
+
(
q(
? /
q8
? (q
Page 2
NSW Multicultural Health Communication Service
Website:
http://mhcs.health.nsw.gov.au
e-mail:
mhcs@sesahs.nsw.gov.au
Page 2 ...
[196]
Prostate cancer: what are the treatment options? (Vietnamese)
[210,8 KB]
From [www.aancart.org] Last viewed: 07.09.2006
Vietnamese
April 2002
[BHC-6055]
1 / 1
DEPARTMENT
Chng ung thi tuy’n ti÷n liŸt vø phiÍng phæp ch?a trfi
Prostate cancer : what are the treatment options?
Nam giÎi cfl mÈt tuy’n nh· s¿n xu`t ra tinh dfich g„i lø mÈt tuy’n ti÷n liŸt. Tuy’n nøy n˜m Ì {æy
bøng quang (b„ng {æi) vø bao quanh Âng ti’t niŸu (lø mÈt Âng nh· dÕn niÎc ti?u t˜ bøng quang ra
diÍng vŒt). T¬i Æc, Ì mÈt thÏi {i?m nøo {fl trong {Ïi mÈt ngiÏi {øn ‰ng, c trong 10 ngiÏi l¬i cfl
mÈt ngiÏi mƒc ph¿i chng ung thi tuy’n ti÷n liŸt. Chng nøy thiÏng x¿y ra Ì nh?ng ngiÏi tr‘n
50 tuÁi vø thiÏng gia tvng trong nh?ng thŒp ni‘n k’ {fl. Tuy nhi‘n, chng ung thi tuy’n ti÷n liŸt
cfl khuynh hiÎng phæt tri?n chŒm vø nh?ng ngiÏi bfi ung thi kh‰ng ch’t v¤ bŸnh nøy.
Ung thi tuy’n ti÷n liŸt lø g¤?
ThiÏng Ì vøo tuÁi trung ni‘n (t˜ 40 trÌ l‘n), tuy’n ti÷n liŸt nÌ lÎn hÍn. V`n {÷ nøy cfl th? gy ra
mÈt s triŸu chng, ch?ng h¬n nhi ...
[197]
Novel therapies: prostate cancer
[170,1 KB]
From [www.pjonline.com] Last viewed: 07.09.2006
prostate
cancer
Study proves new drug fights cancer in prostate
Drug developed in Vancouver blocks protein that helps tumours fight treatment
Pamela Fayerman
Vancouver Sun
Thursday, September 08, 2005
CREDIT: Ian Lindsay, Vancouver Sun
Dan Julien volunteered to be treated with a 'smart drug' for prostate cancer at Vancouver General Hospital. Tests show it worked.
VANCOUVER - After a surgeon removed a cancerous prostate gland from Dan Julien, a gram of the tumour was frozen, ground into a fine powder, and analysed to determine if a "smart drug" developed by doctors at the Vancouver General Hospital's Prostate Centre got into the tissue to do what was intended.
It had. The drug, called OGX-01, inhibited the production of a protein called clusterin that protects cancer cells. The so-called ...
[198]
Surviving prostate cancer
[70,5 KB]
From [www.prostatecancerfoundation.org] Last viewed: 07.09.2006
Surviving prostate cancer
By Christian Toto
THE WASHINGTON TIMES
When Poolesville resident John L. Willey first learned he had prostate
cancer , he went so far as to trail a urologist out of his office and into
the building's elevator to get answers as quickly as possible.
Mr. Willey may be impulsive, but his instincts are sound. The
quicker a prostate cancer patient acts, the better the chance for a
successful recovery.
It's a message Mr. Willey, 60, spreads as a member of the board of
directors of the National Prostate Cancer Coalition in the District.
"It's important people understand what they need to do -- act," Mr.
Willey says.
That's because various health organizations report 1 in 6 men will
get prostate cancer at some point in their lives. The disease typically
strikes men older than 50, though cases in younger men have been
discovered. In its ...
[199]
PROSTATE CANCER PATIENTS BENEFIT FROM NEW THERAPY
[62,2 KB]
From [www.ivinsonhospital.org] Last viewed: 07.09.2006
PROSTATE CANCER PATIENTS BENEFIT FROM NEW THERAPY
AT THE MEREDITH AND JEANNIE RAY CANCER CENTER
Prostate cancer patients are benefiting from brachytherapy, a new technology available at
the Meredith and Jeannie Ray Cancer Center. Prostate brachytherapy is a promising new
treatment in the fight against prostate cancer , and the Meredith and Jeannie Ray Cancer
Center is proud to offer to our patients.
“We are proud to offer this service to our prostate cancer patients. Brachytherapy is a
minor surgical procedure and gives prostate cancer patients in Laramie and southeastern
Wyoming another treatment option for localized prostate cancer ,” explains center
medical oncologist/hematologist, Clinton Merrill, MD. “It represents another important
step forward in our ongoing efforts to bring state-of-the-art cancer care as close to home
as possible to residents of this region.” ...
[200]
OPPORTUNITY PROFILE Prognostic Markers for Prostate Cancer
[101,1 KB]
From [www.monashinstitutes.org] Last viewed: 07.09.2006
Monash Commercial Pty Ltd
ACN 095 891 722
Ground Floor, Administration 3b
Monash University, Victoria 3168, Australia
Telephone: (+61 3) 9905 9515 Facsimile: (+61 3) 9905 5030
www.moncommercial.com
OPPORTUNITY PROFILE
Prognostic Markers for Prostate Cancer
Technology / Product:
The technology involves multiple predictive markers with the potential to distinguish between slow
growing and aggressive prostate cancer . Currently there are no adequate prognostic markers for
prostate cancer . Future products will include:
• Tissue-based diagnostic test to be used on prostate biopsy and surgical tissues
• Blood-based diagnostic test to be used regularly to monitor disease status
Advantages will be to identify patients who need surgical prostate removal and appropriate
chemotherapy treatment, versus patients with latent cancer that can be monitored with ...
[201]
LovelandFYI- Prostate Cancer Foundation hopes to increase ...
[173,8 KB]
From [www.prostatecancerfoundation.org] Last viewed: 07.09.2006
LovelandFYI- Prostate Cancer Foundation hopes to increase awareness of men’s disease
Complete Your Week—Subscribe Today!
Don't miss the complete coverage that will be yours with 7-day convenient home-
delivery of the Reporter-Herald.
News and information from Loveland, Colorado
LovelandFYI Home
News
Local & Regional
Nation & World
Business
Sports
Obituaries
Community
Calendar
Opinion
Editorial
Poll Results
Marketplace
Classifieds
Submit an Ad
Find a Car
Real Estate
Coupons
Entertainment
Cover Story
Dining Guide
Home
|
Local & Regional News
|
Sports
|
Business
|
Opinion
|
Community
...
[202]
1999 Prostate Cancer Research Program Awards Book
[771,4 KB]
From [cdmrp.army.mil] Last viewed: 07.09.2006
Department of Defense
US Army Medical Research and
Materiel Command
Fiscal Year 2002
Prostate Cancer Research Program
Awards List
Table of Contents
Introduction
Fiscal Year 2002 Prostate Cancer Research Program Funded Awards
RESEARCH AWARDS
Consortium Awards
Health Disparity Research – Prostate Scholar Awards
Idea Development Awards
New Investigator Awards
TRAINING/RECRUITMENT AWARDS
Health Disparity Training - Prostate Scholar Award: Predoctoral
Traineeship
Postdoctoral Traineeship Awards
Fiscal Year 2002 Prostate Cancer Research Program Participants
Peer Reviewers
Integration Panel Members
Ad Hoc Programmatic Reviewers
Glossary of Terms
Page 2
Introduction
The US Army Medical Research and Materiel Command (USAMRMC) ...
[203]
1999 Prostate Cancer Research Program Awards Book
[714,9 KB]
From [cdmrp.army.mil] Last viewed: 07.09.2006
Department of Defense
US Army Medical Research and
Materiel Command
Fiscal Year 2003
Prostate Cancer Research Program
Awards List
Table of Contents
Introduction
Fiscal Year 2003 Prostate Cancer Research Program Funded Awards
RESEARCH AWARDS
Exploration: Hypothesis Development Award
Exploration: Resource Development Award
Health Disparity Research – Prostate Scholar Awards
Idea Development Awards
New Investigator Awards
TRAINING/RECRUITMENT AWARDS
Health Disparity Training - Prostate Scholar Award
HBCU Collaborative Partnership Award
Postdoctoral Traineeship Awards
Physician Research Training Award
Fiscal Year 2003 Prostate Cancer Research Program Participants
Peer Reviewers
Integration Panel Members
Ad Hoc Programmatic Reviewers
Glossary ...
[204]
Prostate Cancer
[134,9 KB]
From [www.co.clark.wa.us] Last viewed: 07.09.2006
Clark County Health Department 2003
Prostate Cancer
Clark County and Washington State, 1994 through 2001
Status:
- Clark County's prostate cancer incidence rate has declined since the
early 1990's while the statewide rate is showing a slight increase in
recent years.(3)
-The incidence rate generally increased with age until 70 to 79 years of
age. In most age groups the risk of prostate cancer was higher in men
statewide compared with Clark County men.(3)
- The prostate cancer death rates in both the county and the state
remained steady and were close to meeting the Healthy People 2010
target of fewer than 28.7 deaths per 100,000 population.(4,5,6)
- The majority of persons diagnosed with prostate cancer were
identified in the early stages of the disease indicating the presence of
effective screening programs in this county and statewide. (3)
What we ...
[205]
Prostate Cancer
[94,3 KB]
From [www.aghealth.org] Last viewed: 07.09.2006
NC OFFICE • BATTELLE • CENTERS FOR PUBLIC HEALTH RESEARCH & EVALUATION
100 CAPITOLA DR, SUITE 301 • DURHAM, NC 27713 • 1-800-4AG-STUDY
Prostate Cancer
Spring 2005
Prostate Cancer
Prostate cancer is one of the diseases of
particular interest to the Agricultural Health
Study because it is the most common cancer
among American men and because it has been
reported in other studies to be high among
farmers.
Does research in the Agricultural
Health Study indicate that pesticide
applicators are at increased risk for
prostate cancer ?
Research in the Agricultural Health Study shows
that the incidence of prostate cancer among
licensed restricted-use pesticide applicators is
slightly higher (14%) than it is for other men in
North Carolina and Iowa.
Risk factors observed in other studies—age and a
family history of ...
[206]
New treatments for prostate cancer
[342,7 KB]
From [www.unsw.edu.au] Last viewed: 07.09.2006
8
9
With new funding from the US Army
Medical Research and Materiel Command
(USAMRMC), which has a mandate to
‘provide solutions to medical problems’
for the military, both on and off the
battlefield, Pamela Russell and her team
are expanding their research into these
two areas.
“The first study will investigate the
role of genes thought to be involved in
the spread of prostate cancer to other,
more life-threatening parts of the body,”
said Pamela Russell, “while the second
project is concerned with new treatments
for prostate cancer that seek to target
cancer cells while ignoring their healthy
neighbours.”
Researchers already know that
errors in genetic material or DNA are
responsible for all cancers. Previous
studies at the Oncology Research
Centre have shown that additional
genetic errors might also explain why
...
[207]
Leave for Prostate Cancer Screening
[15,6 KB]
From [www.oswego.edu] Last viewed: 07.09.2006
Leave for Prostate Cancer Screening
From NYS Department of Civil Service
Attendance & Leave Manual
Policy No. 2005-01
Legislation enacted in July 2005 (Chapter 237, Laws of 2004) amended the Civil Service Law to
entitle employees to take up to four hours of paid leave annually for screening for prostate cancer . This
provision took effect on October 25, 2004. A copy of this legislation is attached.
Specifically, a new section of 159-c was added to the Civil Service Law to entitle State officers and
employees to paid leave without charge to leave credits for prostate cancer screening. Employees are
not required to have Attendance Rules coverage to be granted for this leave with pay.
The benefit became available to employees on October 25, 2004 for the remainder of the 2004
calendar year. Beginning January 1, 2005, the benefit because available for the full calendar year. Leave
for this prostate ...
[208]
Diagnosis of prostate cancer
[755,3 KB]
From [www.imego.com] Last viewed: 07.09.2006
www.imego.com
Imego AB, Arvid Hedvalls Backe 4, SE-411 33 Gothenburg, Sweden
Tel. +46 (0) 31 750 18 00. Fax. +46 (0) 31 750 18 01
Diagnosis of prostate cancer
A fast and simple diagnosis of cancer decreases hospital care costs and permits
mass screening of populations, and thereby, earlier diagnoses.The need for such an
instrument exists in particular when it comes to diagnosing prostate cancer .The
appearance of prostate cancer has increased dramatically, and great amounts of
resources are being placed in treatment. Early diagnosis would be accompanied in
part by large economic savings for society and, in another part, would contribute
to improved life quality for patients whose treatment would be considerably more
merciful.
Working together, Imego AB and CanAg Diagnostic AB are developing a new
chip based analysis instrument for quantity detection of cancer . It will replace ...
[209]
Don’t let prostate cancer be a man’s last order About The Prostate ...
[152,7 KB]
From [www.amicustheunion.org] Last viewed: 07.09.2006
Don’t let prostate cancer be a man’s last order
Prostate cancer is the most common male cancer in the UK, with over 27,000 men
diagnosed each year and 10,000 men dying.
Despite these statistics thousands of men over 45 do not know they have a prostate
gland, what it does or how it can go wrong.
To raise awareness of prostate cancer and the prostate gland, The Prostate Cancer
Charity is launching a ‘’Real Man’’ pub campaign during its Prostate Cancer
Awareness Week 21
st
March-27
th
March 2005.
We have designed special drip mats and posters for community pubs whose customers
are mainly men over 45, encouraging them to the “Real Man Test”, a fun quiz which
asks them to answer questions, enter a prize- winning competition and learn about the
prostate gland. If you live in Bradford, Birmingham, Bristol, Liverpool or Glasgow
you can help ...
[210]
WEBINAR CONTINUING EDUCATION Establishing a New Standard of Care ...
[47,8 KB]
From [www.beckmancoulter.com] Last viewed: 07.09.2006
P.A.C.E. #: 030-516-05
FL#: 0000516
WEBINAR CONTINUING EDUCATION
Establishing a New Standard of Care for Prostate Cancer Detection and
Management-PSA/fPSA
1. The most common diagnosed cancer in men is
a. Melanoma
b. Prostate cancer
c. Lung
d. Colon
e. Urinary bladder
2. In screening for prostate cancer , raising the cutoff will decrease the false positive rate and
a. Sensitivity will increase
b. Sensitivity will decrease
c. Sensitivity will not change
d. True negatives will increase
3. A male 50-75 years of age with a nonsuspicious DRE and a total PSA > 10 ng/mL is at
what risk of prostate cancer ?
a. 1%
b. 5%
c. 25%
d. 75%
4. Most PSA circulating in blood is
a. Quickly degraded by a
1
-antichymotrypsin
b. Free (not bound to other proteins)
c. Bound to albumin
d. Bound to a ...